Aromatase inhibitor (anastrozole) affects growth of endometrioma cells in culture
Lab / animal
OA: closed
CC0
⤵ 9 in-corpus citations
AI-generated summary
This study investigated the effect of anastrozole on endometrioma cell growth in culture and observed an impact on their proliferation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To study the effects of aromatase inhibitor (anastrozole) on the growth and estradiol secretion of endometrioma cells in culture.
DESIGN: Endometrioma cells are grown in vitro until maximum growth before used in this study. This was done in the research laboratory for tissue culture, in an academic hospital.
INTERVENTIONS: Testosterone at a concentration of 10 μg/mL was added as a substrate for the intracellular aromatase. In addition, aromatase inhibitor was added at a concentration of 200 and 300 μg/mL. The effect on cell growth and estradiol secretion is evaluated using Student's t-test.
RESULTS: The use of testosterone increased estradiol secretion by endometrioma cells in culture. The use of aromatase inhibitor significantly inhibited the growth of endometrioma cells, and estradiol secretion.
CONCLUSION: Aromatase inhibitor (anastrozole) may be an effective treatment for endometriosis due to inhibition of cellular aromatase.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (34)
- Anastrazole and oral contraceptives: a novel treatment for endometriosis via openalex
- Aromatase and other steroidogenic genes in endometriosis: translational aspects via openalex
- Aromatase expression in endometriosis via openalex
- Aromatase inhibitor treatment limits progression of peritoneal endometriosis in baboons via openalex
- Catamenial hemoptysis and pulmonary endometriosis: a case report via openalex
- Comparison of aromatase inhibitor (letrozole) and immunomodulators (infliximab and etanercept) on the regression of endometriotic implants in a rat model via openalex
- Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen via openalex
- Diagnosis and management of intestinal endometriosis. A report of five cases via openalex
- Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness via openalex
- Endometriosis in premenarcheal girls who do not have an associated obstructive anomaly via openalex
- Endometriosis of the diaphragm: four cases treated with a combination of laparoscopy and thoracoscopy via openalex
- Inhibitory effects of a novel aromatase inhibitor, YM511, on growth of endometrial explants and insulin-like growth factor-I gene expression in rats with experimental endometriosis via openalex
- Peritoneal fluid prostaglandins in patients with endometriosis via openalex
- Postmenopausal endometriosis via openalex
- Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells via openalex
- Prostaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells via openalex
- Subcutaneous Endometriosis in Cesarean Section Scars via openalex
- Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain via openalex
- Therapeutic effect of letrozole in rats with endometriosis via openalex
- Treatment of severe postmenopausal endometriosis with an aromatase inhibitor via openalex
- W2159803441 via openalex
- W1994443458 via openalex
- W1966771586 via openalex
- W2616527804 via openalex
- W4231606105 via openalex
- W1573126284 via openalex
- W868417270 via openalex
- W6641930901 via openalex
- W6656356435 via openalex
- W6658210289 via openalex
- W6716922584 via openalex
- W6719777743 via openalex
- W2145213731 via openalex
- W6814680148 via openalex
Cited by (11)
- How could the prolonged precycle administration of aromatase inhibitors affect the in vitro fertilization and embryo transfer (IVF-ET) outcomes of patients with endometriosis? 2026
- The in vitro and in vivo effects of the hormonal agents on the endometriotic and adenomyotic lesions 2026
- Hormonal Therapies before in vitro fertilization in women with endometriosis: The Minotaur's Labyrinth and the Ariadne's Thread 2024
- Hormonal Therapies before In-Vitro Fertilization in Women with Endometriosis 2024
- Aromatase Inhibitors Use for Endometriosis Patients 2020
- Effect of local aromatase inhibition in endometriosis using a new chick embryo chorioallantoic membrane model 2019
- Pharmacological Management of Chronic Pelvic Pain in Women 2017
- Investigational Medical Therapies for Endometriosis: Current Data and Future Trends 2017
- Huge Retroperitoneal Endometriotic Mass Adherent to the Sheaths of the Great Pelvic Vessels: 10 Years After Panhysterectomy (Parasitic Endometriosis) 2017
- Summary of Future Developments 2017
- Aromatase Inhibitors for Endometriosis-Associated Infertility; Do We Have Sufficient Evidence? 2016
Source provenance
- europepmc
- last seen: 2026-10-25T09:32:14.900964+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:15:21.500443+00:00
- unpaywall
- last seen: 2026-10-25T06:24:14.523685+00:00
License: CC0
· commercial use OK